BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/30/2022 6:33:07 PM | Browse: 140 | Download: 200
Publication Name World Journal of Cardiology
Manuscript ID 79582
Country United States
Category Cardiac & Cardiovascular Systems
Manuscript Type Systematic Reviews
Article Title Telemonitoring in heart failure patients: Systematic review and meta-analysis of randomized controlled trials
Manuscript Source Unsolicited Manuscript
All Author List Chukwuemeka Anthony Umeh, Adrian Torbela, Shipra Saigal, Harpreet Kaur, Shadi Kazourra, Rahul Gupta and Shivang Shah
Funding Agency and Grant Number
Corresponding Author Chukwuemeka Anthony Umeh, MD, Attending Doctor, Internal Medicine, Hemet Global Medical Center, 1117 E Devonshire Ave, Hemet, CA 92543, United States. emmyumeh@gmail.com
Key Words Telemonitoring; Heart failure; Telehealth; Home monitoring; Remote monitoring
Core Tip Home telemonitoring has been used as a modality to prevent readmission and improve outcomes for patients with heart failure. However, studies have produced conflicting outcomes over the years. This meta-analysis aims to determine the aggregate effect of telemonitoring on all-cause mortality, heart failure-related mortality, all-cause hospitalization, and heart failure-related hospitalization in heart failure patients. This study found that home telemonitoring using digital/broadband/satellite/wireless or blue-tooth transmission of physiological data reduces all-cause and cardiovascular mortality in heart failure patients. Additionally, prolonged home telemonitoring (12 mo or more) led to both decreased all-cause and heart failure hospitalization, unlike shorter duration (6 mo or less) telemonitoring. The implication for practice is that hospitals considering telemonitoring to reduce heart failure readmission rates may need to plan for prolonged telemonitoring to see the effect they are looking for.
Citation Umeh CA, Torbela A, Saigal S, Kaur H, Kazourra S, Gupta R, Shah S. Telemonitoring in heart failure patients: Systematic review and meta-analysis of randomized controlled trials. World J Cardiol 2022; 14(12): 640-656
Received
2022-08-28 03:03
Peer-Review Started
2022-08-28 03:06
First Decision by Editorial Office Director
2022-10-24 02:56
Return for Revision
2022-10-24 02:56
Revised
2022-11-02 02:58
Publication Fee Transferred
Second Decision by Editor
2022-11-30 03:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2022-11-30 18:33
Articles in Press
2022-11-30 18:33
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-12-12 09:05
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com